Understanding how Francisella bacteria cause disease
Identity, function and control of Francisella effectors encoded outside its pathogenicity island
This study is looking at how a harmful germ called Francisella tularensis makes people sick by using certain proteins to help it grow inside our cells, and the goal is to find new ways to understand and treat infections caused by this germ.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10668260 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which Francisella tularensis, a highly virulent bacterium, causes infections in humans. The team will explore specific proteins that the bacteria use to enhance their ability to replicate inside host cells. By examining these proteins and their genetic locations, the researchers aim to uncover new insights into the bacteria's virulence strategies. This work could lead to better understanding and potential treatments for infections caused by this dangerous pathogen.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who may be at risk of exposure to Francisella tularensis, particularly those in certain occupational or environmental settings.
Not a fit: Patients who are not at risk of exposure to Francisella tularensis or who have no history of related infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments or preventive measures against infections caused by Francisella tularensis.
How similar studies have performed: Other research has shown success in understanding bacterial virulence mechanisms, but this specific approach to studying Francisella tularensis is relatively novel.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Mougous, Joseph David — University of Washington
- Study coordinator: Mougous, Joseph David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.